PT - JOURNAL ARTICLE AU - Grace Bagwell Adams AU - Jerry Shannon AU - Sarah Shannon TI - “Return to University Campuses Associated with 9% Increase in New COVID-19 Case Rate” AID - 10.1101/2020.10.13.20212183 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.13.20212183 4099 - http://medrxiv.org/content/early/2020/10/14/2020.10.13.20212183.short 4100 - http://medrxiv.org/content/early/2020/10/14/2020.10.13.20212183.full AB - The vast majority of colleges and universities across the United States are bringing students back for in-person instruction in the midst of the COVID-19 pandemic, despite the absence of an effective vaccine or other anti-viral therapeutic treatment. Using data from the New York Times and the American Community Survey, we assess the effect of this return to campus on viral case growth in counties with a significant college student population (“college counties”) relative to non-college counties. We find a significant surge in new cases in a 21-day time frame in college counties, a finding consistent across U.S. Census divisions. These results suggest the need for institutions of higher education and the communities where these institutions reside work together quickly and effectively to mitigate viral transmission and to prevent overwhelming local healthcare infrastructure in college counties.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received to support the work presented in this paper.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data used are secondary data aggregated to the county level and are not subject to IRB approval.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available from the GitHub link posted below. https://github.com/nytimes/covid-19-data/tree/master/colleges